Epidemiology
Patients, n
21
Sex ratio (M/F)
9/12
Mean age, years
47.7
Clinical
DDD
Pure
12 (57.1 %)
Revision
9 (42.9 %)
Levela
L2–L3
4 (12.1 %)
L3–L4
19 (57.6 %)
L4–L5
10 (30.3 %)
Posterior fixationb
PeSFix
15 (78.9 %)
InterFix
4 (21.1 %)
There were no major surgical complications. Immediate postoperative hip flexion weakness and transient upper thigh numbness due to transitory nerve injury during the transpsoas approach were present in 53 % of patients but extremely variable. These complications were generally resolved within the first 4–6 weeks after surgery. Only one patient presented with a postoperative L4 motor deficit, which persisted 1 year before the final incomplete recovery.
Seventy percent of patients presented with pain and functional impairment of thigh flexion and intrarotation due to psoas contracture. These symptoms generally resolved in 2–4 weeks with the aid of NSAIDs and myorelaxants. Table 18.2 shows the early postoperative approach-related complications.
Table 18.2
Complications
Death | 0 |
Hip flexion weakness | 3 (11.1 %) |
Upper thigh numbness | 9 (42.9 %) |
Radicular deficit | 1 (4.8 %) |
The mean follow-up time was 32 months (range 18–48 months). Table 18.3 summarizes the results of the clinical test VAS, ODI, and SF-36. All of the tests were administered during the preoperative period, postoperative period (30 days after surgery), and at the last follow-up.
Table 18.3
Evaluation tests
ODI | VAS | SF-36 | ||||||
---|---|---|---|---|---|---|---|---|
Pre-op | 0–20 | 0 (0 %) | Pre-op | 0–2 | 0 (0 %) | |||
40 | 2 (9.5 %) | 4 | 3 (11.1 %) | Mental | Pre-op | 37.50 % | ||
60 | 8 (38.1 %) | 6 | 8 (38.1 %) | Post-op | 56.35 % | |||
80 | 9 (42.9 %) | 8 | 9 (42.9 %) | FU | 60.22 % | |||
100 | 2 (9.5 %) | 10 | 1 (4.8 %) | p-value | 0.0012 | |||
Mean | 65.7 | Mean | 6.97 | Physical | Pre-op | 29.72 % | ||
p-value | 0.0001 | p-value | 0.0005 | Post-op | 42.58 % | |||
Post-op | Improved | 13 (61.9 %) | Post-op | Improved | 11 (57.1 %) | FU | 55.15 % | |
Stable | 8 (38.1 %) | Stable | 9 (42.9 %) | p-value | 0.009 | |||
Worse | 0 (0 %) | Worse | 0 (0 %) | |||||
Mean | 37.5 | Mean | 4.97 | |||||
p-value | 0.0005 | p-value | 0.0012 | |||||
Follow-up | Improved | 20 (95.2 %) | Follow-up | Improved | 21 (100 %) | |||
Stable | 1 (4.8 %) | Stable | 0 (0 %) | |||||
Worse | 0 (0 %) | Worse | 0 (0 %) | |||||
Mean | 16.8 | Mean | 2.35 | |||||
p-value | 0.0013 | p-value | 0.002 |
18.3.1 Demonstrative Cases
18.3.1.1 Case 1
A 51-year-old man presented with chronic axial low back pain. From 6 months the pain was unbearable. He underwent physical therapy without resolution of the symptoms. MRI revealed DDD at L4–L5 with no signs of instability in the dynamic X-ray. The results of the preoperative clinical tests were as follows: ODI = 54 %, VAS = 7.1, SF-36 mental = 33.68 mental, and SF-36 physical = 35.23. He underwent LIF at L4–L5 and received a posterior interspinous stabilization device.
18.3.1.2 Case 2
A 77-year-old woman presented with intense chronic low back pain. It was 10 years before stabilization at L4–L5 due to a degenerative spondylolisthesis (Steffee Implant). X-ray examinations demonstrated breakage of the L5 right screw and a collapse of the disk space. The results of the preoperative clinical tests were as follows: ODI = 84 %, VAS = 8.2, SF-36 mental = 31.32, and SF-36 physical = 31.45. She underwent L4–L5 LIF with restoration of the foramina height, but she complained of postoperative transient upper thigh numbness.
18.3.1.3 Case 3
A 39-year-old woman presented with progressively low back pain. She underwent extensive physical and cognitive therapy without resolution of the symptoms. MRI examinations revealed DDD at L4–L5 with indirect signs of microinstability but no listhesis in the dynamic X-ray. The results of the preoperative clinical tests were as follows: ODI = 63 %, VAS = 6.1, SF-36 mental = 39.37, and SF-36 physical = 35.40. She underwent XLIF at L4–L5 with posterior percutaneous stabilization and achieved complete resolution of symptoms.
18.4 Discussion
The extreme lateral approach has been successfully proposed for treating DDD in the thoracolumbar spine, but the indications are still controversial and the literature lacks consistent and long-term clinical results [24]. Although few studies have reported outcomes specifically for DDD patient cohorts following XLIF, the minimal invasiveness of the surgical approach with careful patient selection and preoperative evaluation of both radiographic and clinical symptoms seem to be determinant factors for obtaining the best results.
In Marchi et al.’s series of 22 patients treated with XLIF, the fusion rate was 93 % with 70 % improvement in back pain and 53 % improvement in ODI. Patients in this series also experienced short operative times (average 72 min), low mean blood loss (50 mL), and short length of stay (1 day) [21]. Berjano et al. reported on the preliminary clinical results of a series of 97 patients, 80 % of whom were classified as having DDD. In their study, clinical improvement was reported to be 61.3 %, leg pain improved 64 %, and ODI improved 55 %. Only a few complications were described, such as L4 transient weakness that resolved in 1 month and transient crural or tight hypoesthesia in 11 patients [22].
Interestingly, Khajavi et al. compared their results for patients undergoing XLIF for DDD with an adjunct minimally invasive posterior approach to results obtained by Gassman et al. with patients undergoing standard open surgery for DDD. Patients treated with XLIF had improved clinical outcomes at the last follow-up (24 months postoperative), 46 % for ODI, 65 % for low back pain, 55 % for leg pain, and 45 % for the physical component of SF-36. Furthermore, at the 24-month follow-up, the scores for patients who underwent XLIF were favorable to the scores of patients who underwent standard posterior open surgery, with the exception of ODI [8, 25, 26].